Lv5
978 积分 2024-05-14 加入
Safety, Tolerability and Pharmacokinetics of Sugammadex Using Single High Doses (Up to 96 mg/kg) in Healthy Adult Subjects
1小时前
待确认
Pharmacokinetics of Sugammadex: An Open‐Label, 3‐Period, Fixed‐Sequence, 3‐Single‐Doses Study in Healthy Chinese Subjects
1小时前
待确认
First Human Exposure of Org 25969, a Novel Agent to Reverse the Action of Rocuronium Bromide
2小时前
待确认
Signaling pathways in brain ischemia: Mechanisms and therapeutic implications
1个月前
已完结
Drugs/agents for the treatment of ischemic stroke: Advances and perspectives
1个月前
已完结
[Applications of microneedles in non-transdermal drug delivery: a review]
3个月前
已完结
Under-dosing and over-dosing of neuromuscular blocking drugs and reversal agents. Response to Br J Anaesth 2024; 132: 461–5
3个月前
已完结
Under-dosing and over-dosing of neuromuscular blocking drugs and reversal agents: beware of the risks
3个月前
已完结
Advances in Polysaccharide-Based Microneedle Systems for the Treatment of Ocular Diseases
3个月前
已完结
Sugammadex-Induced Bradycardia and Anaphylaxis and Proposed Mechanism for Adverse Events
6个月前
已完结
皖公网安备34019202002308
